Literature DB >> 12410479

Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1).

Jeffrey I Cohen1, David S Davenport, John A Stewart, Scott Deitchman, Julia K Hilliard, Louisa E Chapman.   

Abstract

B virus (Cercopithecine herpesvirus 1) is a zoonotic agent that can cause fatal encephalomyelitis in humans. The virus naturally infects macaque monkeys, resulting in disease that is similar to herpes simplex virus infection in humans. Although B virus infection generally is asymptomatic or mild in macaques, it can be fatal in humans. Previously reported cases of B virus disease in humans usually have been attributed to animal bites, scratches, or percutaneous inoculation with infected materials; however, the first fatal case of B virus infection due to mucosal splash exposure was reported in 1998. This case prompted the Centers for Disease Control and Prevention (Atlanta, Georgia) to convene a working group in 1999 to reconsider the prior recommendations for prevention and treatment of B virus exposure. The present report updates previous recommendations for the prevention, evaluation, and treatment of B virus infection in humans and considers the role of newer antiviral agents in postexposure prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410479     DOI: 10.1086/344754

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  36 in total

1.  Primates and primatologists: social contexts for interspecies pathogen transmission.

Authors:  G A Engel; L Jones-Engel
Journal:  Am J Primatol       Date:  2011-09-19       Impact factor: 2.371

2.  Comparative Risk of Human Injury/Exposure While Collecting Blood from Sedated and Unsedated Nonhuman Primates.

Authors:  Charlotte E Hotchkiss; Melinda A Young
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-06-11       Impact factor: 1.232

3.  Discovery of herpes B virus-encoded microRNAs.

Authors:  Michael I Besecker; Mallory E Harden; Guanglin Li; Xiu-Jie Wang; Anthony Griffiths
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

4.  The infectious diseases consequences of monkey business.

Authors:  Jm Conly; Bl Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

Review 5.  Mammalian alphaherpesvirus miRNAs.

Authors:  Igor Jurak; Anthony Griffiths; Donald M Coen
Journal:  Biochim Biophys Acta       Date:  2011-06-28

6.  Genistein Has Antiviral Activity against Herpes B Virus and Acts Synergistically with Antiviral Treatments to Reduce Effective Dose.

Authors:  Julia C LeCher; Nga Diep; Peter W Krug; Julia K Hilliard
Journal:  Viruses       Date:  2019-05-31       Impact factor: 5.048

Review 7.  Microbiology of animal bite wound infections.

Authors:  Fredrick M Abrahamian; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

8.  Discrimination of antibody to herpes B virus from antibody to herpes simplex virus types 1 and 2 in human and macaque sera.

Authors:  Akikazu Fujima; Yoshitsugu Ochiai; Aya Saito; Yuki Omori; Atsuya Noda; Yukumasa Kazuyama; Hiroshi Shoji; Kiyoshi Tanabayashi; Fukiko Ueda; Yasuhiro Yoshikawa; Ryo Hondo
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

9.  B-virus (Cercopithecine herpesvirus 1) infection in humans and macaques: potential for zoonotic disease.

Authors:  Jennifer L Huff; Peter A Barry
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

10.  Recommendation for post-exposure prophylaxis after potential exposure to herpes b virus in Germany.

Authors:  Thomas Remé; Klaus Dieter Jentsch; Juliane Steinmann; Stephanie Kenner; Ulrich Straile; Eberhard Buse; Andreas Sauerbrei; Franz-Josef Kaup
Journal:  J Occup Med Toxicol       Date:  2009-11-26       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.